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Abstract
Background: CD4+/CD8+ double positive (DP) T cells have been described in healthy individuals as well as in patients with
autoimmune and chronic infectious diseases. In chronic viral infections, this cell subset has effector memory phenotype and
displays antigen specificity. No previous studies of double positive T cells in parasite infections have been carried out.
Methodology/Principal Findings: Seventeen chronic chagasic patients (7 asymptomatic and 10 symptomatic) and 24 non-
infected donors, including 12 healthy and 12 with non-chagasic cardiomyopathy donors were analyzed. Peripheral blood
was stained for CD3, CD4, CD8, HLA-DR and CD38, and lymphocytes for intracellular perforin. Antigen specificity was
assessed using HLA*A2 tetramers loaded with T. cruzi K1 or influenza virus epitopes. Surface expression of CD107 and
intracellular IFN-c production were determined in K1-specific DP T cells from 11 chagasic donors. Heart tissue from a chronic
chagasic patient was stained for both CD8 and CD4 by immunochemistry. Chagasic patients showed higher frequencies of
DP T cells (2.1%60.9) compared with healthy (1.1%60.5) and non-chagasic cardiomyopathy (1.2%60.4) donors. DP T cells
from Chagasic patients also expressed more HLA-DR, CD38 and perforin and had higher frequencies of T. cruzi K1-specific
cells. IFN-c production in K1-specific cells was higher in asymptomatic patients after polyclonal stimulation, while these cells
tended to degranulate more in symptomatic donors. Immunochemistry revealed that double positive T cells infiltrate the
cardiac tissue of a chagasic donor.
Conclusions: Chagasic patients have higher percentages of circulating double positive T cells expressing activation markers,
potential effector molecules and greater class I antigenic specificity against T. cruzi. Although K1 tetramer positive DP T cell
produced little IFN-c, they displayed degranulation activity that was increased in symptomatic patients. Moreover, K1-
specific DP T cells can migrate to the heart tissue.
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Introduction
Expression of either CD4 or CD8 on mature peripheral CD3+
T cells is considered to be a mutually exclusive event as a result of
the thymic selection, reflecting the specific functions of each major
T cell subpopulation. Contrary to this conventional dichotomy,
circulating CD4+/CD8+ double positive (DP) T cells have been
identified in human peripheral blood and represents between 1
and 3% of the total T lymphocytes population [1]. The role of
these DP T cells in health and disease is still under investigation.
Some healthy individuals can display a significant proportion of
DP T cells in peripheral blood. Furthermore, previous evidence
has suggested that their frequency in blood can increase or they
can be localized in specific tissues during several inflammatory
diseases [2–8], including: a) chronic viral diseases, like EBV
infectious mononucleosis [3] and HIV [4]; b) autoimmune
pathologies characterized by chronic lymphocytes activation, such
as autoimmune thyroiditis [5], myasthenia gravis [6] and systemic
sclerosis/scleroderma [7]; c) allergy i.e. atopic dermatitis [8] and d)
some neoplasias [3,9].
Based on the intensity of CD4 and CD8 expression by flow
cytometry, two subsets of DP T cells have been defined: CD4
dim/
CD8
bright and CD4
bright/CD8
dim lymphocytes [3]. Previous
studies of their phenotypic characteristics have shown that the
majority of these cells have memory phenotype (CD45RO+). They
are also more differentiated than mono-positive T cells, based on
www.plosntds.org 1 August 2011 | Volume 5 | Issue 8 | e1294its low level of expression of CD27, and they frequently produced
either intracellular granzyme B or perforin [10,11]. Functional
assays showed that during chronic viral infections, DP T cells
secrete cytokines, such as IFN-c, in response to cognate class I
restricted antigens [10]. All these results suggest that, although
small, DP T cells constitute a highly differentiated memory
subpopulation acting in the adaptive immune response against
infectious agents [1–4,10,11].
As this cell population is expanded in several viral and
immunological mediated chronic diseases, it seems plausible that
DP T cells can contribute to the immune response against chronic
parasitic infections. The goal of this study was to determine the
frequency, phenotype and effector potential of circulating DP T
cells in patients chronically infected with T. cruzi, the etiological
agent of Chagas disease. This hemoflagellate parasite, which is
found in Central and South America, is transmitted by vectors of
the Reduviidae family and produces both an acute and a chronic
phase [12,13]. Prevalence of Chagas diseases in Colombia is
calculated to be 1’300,000, while 3’500,000 people are at risk of
contracting the infection, representing a potential public health
problem [13,14]. After T. cruzi inoculation, during the acute
phase, the parasite extracellular stages are found in peripheral
blood and infected individuals develop constitutive symptoms.
Activation of the immune system allows parasite control, although
it is not completely eliminated. Parasites invade cells such as
monocytes/macrophages, dendritic cells, fibroblast and myocar-
diocytes, shedding their flagella and becoming intracellular [15].
By mechanisms not clearly understood, parasites persist leading to
the chronic phase of the disease. Most of the infected individuals
will remain asymptomatic for several years, being classified as
indeterminate. Those patients are usually detected by routine
serological tests in blood banks. Nearly 20% to 30% of the chronic
infected patients will develop tissue damage, being Chagasic
cardiomyopathy or digestive disease the most common pathologies
[12,13]. What mediates the tissue damage in Chagas is not well
understood, but some evidence suggests that parasite persistence
and dysfunctional cellular immune response could contribute to
this process [12,15]. During the infection, antibodies elicited
against T. cruzi antigens help to control blood circulating parasite
[16,17] and specific CD4+ and CD8+ T cells act against
intracellular forms [18,19]. Mice models demonstrated that T
cells response seemed to be crucial for parasite control [20].
Interestingly, acute infection with T. cruzi in mice showed a large
increase of CD4+/CD8+ DP T cells in their subcutaneous lymph
nodes [21]. Given the characteristics of the DP T cells (memory
phenotype and presence of cytotoxic granules), it is of special
interest to determine their functional characteristics in chronic
chagasic patients.
Methods
Ethics statement
Research protocols and informed consents were approved by
the Ethical Committees of the Universidad de los Andes (039-
2009), Pontificia Universidad Javeriana (01-2010) and the
Fundacio ´n Abood Shaio (134-2010), Bogota ´, Colombia, following
the national regulations and the Declaration of Helsinki.
Human donors
Forty-one volunteers who signed the informed consent were
enrolled in this study and divided into three groups. The first
group included 17 chronic chagasic patients with positive
immunofluorescence indirect assay (IFI) and ELISA tests. It was
composed of 13 females and 4 males with ages ranging from 36 to
67 years old, recruited at the Fundacio ´n Abood Shaio (Bogota ´,
Colombia) or at Instituto Nacional de Salud; and classified
according to the Kuschnir grading system [22]. Seven individuals
were classified as indeterminate chagasic patients with no
significant findings during clinical assessment (G0 or asymptom-
atic) and 10 as cardiac chronic chagasic patients (symptomatic)
graded as follows: 3 with only abnormal ECG results (G1), 5 with
abnormal ECG results and cardiac enlargement (G2) and 2 with
abnormal ECG results, cardiac enlargement and clinical signs of
heart failure (G3). The second group included 12 donors with
cardiomyopathy of non-infectious etiology, including 8 females
and 4 males with ages ranging from 28 to 80 years old, and whose
anti-T. cruzi antibodies were negative. In this group, cardiomyop-
athy etiology was: ischemic cardiomyopathy (n=6), systemic
arterial hypertension (n=4) and idiopathic dilated cardiomyopa-
thy (n=2). This group of patients was recruited at the Department
of Cardiology, Hospital Universitario San Ignacio, Bogota ´,
Colombia. The third group included 12 uninfected donors who
never lived in a Chagas endemic area, and with negative IFI and
ELISA tests. They were 9 females and 3 males with ages ranging
from 34 to 68 years old. The characteristics of the three groups,
denoted as chagasic patients (CP), non-chagasic cardiomyopathy
(NCC) and healthy controls (HC), including main clinical,
electrocardiogram and echocardiography findings, are resumed
in Table 1.
Blood sample and cell surface phenotype
Blood samples were obtained from each donor using EDTA
vacuntainer tubes. Total blood (100 ml/tube) was stained with
anti-CD3 APC (clone SK7), anti-CD4 PerCP (SK3), anti-CD8 PE
(RPA-T8), anti-HLA-DR PE-Cy7 (L243) and anti-CD38 FITC
(HIT2). All monoclonal antibodies were purchased from BD
Bioscience (San Jose, CA, USA). Blood was stained in darkness for
30 minutes at 4uC and incubated with cell lysis buffer (BD
Bioscience) for 10 minutes at room temperature. Then, cells were
washed twice in PBS 0.01 M pH 7.4 and gently re-suspended.
Samples were acquired and analyzed in a FACS Canto II with
FACSDiva software (BD Bioscience). At least 5610
4 cells were
Author Summary
Chagas disease, produced by the blood parasite Trypano-
soma cruzi, is considered a public health problem in
Central and South America. Non sterile immunity can be
achieved after acute infection. Parasite persistence can
induce tissue damage in nearly 20% to 30% of chronically
infected individuals. Indeed, chagasic cardiomyopathy is
one of the consequences of the chronic infection. Antigen
persistence and dysfunctional cellular immune response
have been implicated in T. cruzi pathogenesis. Here, a
higher frequency of circulating CD4+/CD8+ double posi-
tive T cells in chronic chagasic patients is reported as
compared with non infected donors, including those with
a non-chagasic cardiomyopathy. This cell subset also
expressed more activation markers and stored more
intracellular perforin. We have previously reported that
CD8+ T cells from T. cruzi infected donors recognized the
HLA-A*0201 restricted K1-peptide derived from the KMP-
11 protein. Here, double positive T cells displayed higher
percentages of recognition for the K1 peptide than single
CD8+ T cells. These cells produce little IFN-c, but display
degranulation activity that was increased in the symptom-
atic group. Finally, double positive T cells can be localized
in the heart tissue from a chronic chagasic donor.
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forward scatter (FSC) versus side scatter (SCC) features. Dead cells
were excluded by light scatter (FSC-H versus FSH-A). All data
shown for CD4+/CD8+ DP T cells are based on the CD3+ gate.
Staining for intracellular markers
Analysis was done with 2610
6 of peripheral blood mononuclear
cells (PBMC) from each individual, obtained by ficoll-hypaque
density gradient (Sigma, St. Louis, MO, USA). Viability was
assessed by trypan blue exclusion (Sigma). Surface staining was
done with antibodies against CD3 APC, CD4 PerCP and CD8
PE-Cy7 for 30 minutes at 4uC. After one wash, the cell membrane
was permeated with Cytofix/Cytoperm solution for 20 minutes at
4uC, followed by washing with Perm/Wash 16(BD Bioscience).
Intracellular staining was done with anti-perforin FITC antibody
(clone dG9) or mouse IgG2b isotype control (clone 27–35) for
30 min at 4uC. Lastly, cells were washed, re-suspended and
analyzed as described above. At least 2610
5 CD3+ cells were
recorded by flow cytometry and perforin expression was
determined in CD4+/CD8+ gate.
Class I antigen specific double positive cells
As HLA-A2 is one of the most common class I allele in
Colombia [23], donors were typed for HLA-A2 and subtype for
HLA-A*0201 by flow cytometry and SS-PCR as previously
described [24,25]. Tetramer analysis was only done in HLA-
A*0201+ individuals, including: 13 chagasic donors (6 asymptom-
atic and 7 symptomatic) and 5 healthy controls. Cells were
incubated with anti-CD3 APC, anti-CD4 PerCP, anti-CD8 PE-
Cy7 and anti-HLA-A*0201 PE tetramers loaded either with T.
cruzi or influenza virus derived epitopes. T. cruzi epitope or K1, is a
9 mer peptide (TLEEFSAKL) derived from N-terminal region
(amino acids 4–11) of T. cruzi KMP-11 protein (Swiss-Prot
accession number: Q9U6Z1) [24,25]. Influenza virus peptide
was a modified epitope derived from the viral matrix proteins (a.a.
58–66) denominated MP-Flu (GILGFVTTL) [25]. Tetramers
were synthesized by the National Institute of Health (NIH)
Tetramer Facility (Atlanta, USA). At least 2610
5 cells were
analyzed by flow cytometry in the CD3+ gate and tetramer
expression was determined in the CD4+/CD8+ gates.
Cell stimulation, degranulation and IFN-c production
PBMC from 5 asymptomatic (G0) and 6 symptomatic patients
(two of each: G1, G2 and G3) were isolated using density gradient
as described above. A total of 2610
6 PBMC were culture in the
presence of anti-CD28 (1 mg/ml) and anti-CD49d (1 mg/ml) and
one of the following conditions: medium alone, 10 mg/ml of K1
peptide or 3.7 mg/ml of Staphylococcal enterotoxin B (SEB).
Cultures were incubated for 3 hours at 37uC with 5% of CO2,
followed by an additional 6 hours of incubation in the presence of
Brefeldin A 10 mg/ml (BD Pharmingen). For degranulation assays,
anti-CD107a and CD107b FITC (clones H4A3 and H4B4,
respectively) were added immediately following stimulation. For
surface staining, antibodies for CD3-Pacific Blue (UCHT1), CD4-
PeCy5.5 (SK3), CD8-APCH7 (SK1) and K1 PE tetramer were
used. PBMC were washed once and then fixed/permeated using
Cytofix/Cytoperm (BD Bioscience). Cells were washed twice with
Perm/Wash 16 (BD Bioscience), stained with 10 ml anti-IFN-c
PE-Cy7 (clone B27), rewashed once and re-suspended in FACs
Flow (BD Bioscience). Population was gated according viability
and CD3 expression. Expression of CD107 and production of
IFN-c was based on the K1 tetramer positive CD4+/CD8+ cells.
At least 1610
3 tetramer positive cells were acquired and analyzed
in a FACS Aria with FACSDiva software (BD Bioscience).
Histology studies in cardiac tissue
Cardiac tissue from a chronic chagasic patient biopsy was used
for immunochemistry. This specimen was obtained from a 47 year
old male who was diagnosed with cardiac failure class III (NYHA
classification) and underwent a cardiac transplant. Formalin-fixed
and paraffin-embedded cardiac biopsy tissue was cut, deparaffi-
nized in xylene and rehydrated with alcohol. Antigen retrieval was
Table 1. Characteristics of the studied individuals.
Characteristics Groups
CP (n=17) NCC (n=12) HC (n=12)
Age (years), mean 6 SD* 52.8610.2 62.4615.2 51.7611.2
Age range 36–67 28–80 34–68
Female No (%)** 13 (76.5) 8 (66.7) 9 (75.0)
Asymptomatic Symptomatic
G0 (n=7) G1 (n=3) G2 (n=5) G3 (n=2)
LVEF % Mean 6 SD 55.065.8 58.7611.8 50.5617 35.067.1 43.8613.7 -
Atrial fibrillation - 1 - - 2 -
Anterior myocardial infarction - - - - 1 -
Atrioventricular block-I 1 - 1 - - -
Atrioventricular block - - - 2 - -
Right bundle branch block - 2 2 - 1 -
Sinus bradycardia 1 - 2 - 4 -
Normal ECG 5 - - - - -
Groups: CP chagasic patients, NCC non-chagasic cardiomyopathy donors and HC healthy controls. Atrioventricular block-I (first degree), LVEF left ventricular ejection
fraction.
*p value: 0.08 and.
**p value: 0.89.
doi:10.1371/journal.pntd.0001294.t001
Double-Positive T Cells in Chagas Disease
www.plosntds.org 3 August 2011 | Volume 5 | Issue 8 | e1294Figure 1. Percentage of circulating DP T cells in Chagasic patients and uninfected controls. (A) Representative dot plots of flow
cytometry and gating strategy showing CD4+/CD8+ T cells subsets (CD4
highCD8
low and CD4
lowCD8
high) in chagasic patients (CP), healthy controls
(HC) and non-chagasic cardiomyopathy (NCC) groups. DP T population was gated on lymphocytes (FSC versus SSC), viability and CD3 positive cells.
(B) Averaged percentage with standard deviations (SD) of total CD4+/CD8+ T cells in PBMC from CP (black bars), HC (gray bars) and NCC (empty bars).
(C) Comparison of averaged percentage of CD4
high/CD8
low (gray bars) or CD4
low/CD8
high (empty bars) T subsets and their standard deviations.
*p,0.05 by Kruskal Wallis.
doi:10.1371/journal.pntd.0001294.g001
Figure 2. Activation markers in DP T cells from Chagasic patients and uninfected controls. (A) Representative density plots of CD38 and
HLA-DR expression on DP T cells gated as indicated in Figure 1A from chagasic patients (CP), healthy controls (HC) and non-chagasic cardiomyopathy
(NCC) donors. The percentage of CD38 and HLA-DR positive cells is shown in each quadrant. (B) Averaged percentage of HLA-DR+ events in CD4
high/
CD8
low (gray bars) or CD4
low/CD8
high (empty bars) T cells. (C) Co-expression of CD38 and HLA-DR in CD4
high/CD8
low (gray bars) or CD4
low/CD8
high
(empty bars) T cells and their standard deviations. *p,0.05 by Kruskal Wallis.
doi:10.1371/journal.pntd.0001294.g002
Double-Positive T Cells in Chagas Disease
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Slides were stained with hematoxylin/eosin to evaluate cellular
infiltration and presence of parasites. Immunohistology was
carried out with anti-human CD4 (clone 1F6, Vector Laborato-
ries, Burlingame, CA, USA) and CD8 (C8/144B, DakoCytoma-
tion, Carpinteria, CA, USA) antibodies. After blocking endoge-
nous enzymes, antibodies were revealed with EnVision
TM G|2
Doublestain System kit (DakoCytomation) using peroxidase/
DAB+ Chromogen for CD8 and then alkaline phosphatase/
Permanent Red Chromogen for CD4. Slides were evaluated in a
light microscope (40–1006objective magnification) where CD8+
cells yielded a brown-color and CD4+ a red-color end product;
DP T cells showed a red-brown color.
Statistical analysis
Descriptive statistics (mean, standard deviation and percentages)
was used to describe the populations and to present the flow
cytometry data. Non-parametric analysis was carried out (Statistix
8.0 software) for groups comparisons by Kruskal Wallis (K-W) test
followed by Dunn post hoc tests. Comparison of two groups was
done by Mann-Whitney U test (M-W). Significance was
considered a p value,0.05.
Results
Phenotype analysis of double positive T cells
Cell frequency between chronic chagasic patients (CP) and
healthy controls (HC) matched by age and gender were compared.
The average percentage of total circulating DP T cells was higher
(p=0.0017) in CP (X=2.1%60.9) compared with HC group
(1.160.5) (Figure 1B). Representative flow cytometry dot plots and
gating strategy are shown in Figure 1A. To determine if this
difference was attributed to the chagasic patients immune response
and not to the cardiac damage or its pathological consequences,
DP T cells percentages from CP were compared with those from
donors with non-chagasic cardiomyopathy (NCC) (Figure 1A and
1B). Likewise, DP T cells frequency from CP was higher
(p=0.034) compared with NCC group (X=1.260.4). For the
following analysis, DP T cells were divided according to their
phenotype into CD4
high/CD8
low and CD4
low/CD8
high. The
frequency of CD4
high/CD8
low T cell was higher (p=0.0058) in
CP (X=1.61%60.87) than in HC (0.8860.56) and NCC
(0.8760.41) donors (Figure 1C). Regarding to CD4
low/CD8
high
T cell, significant differences were only observed between CP and
HC (p=0.015) frequencies (Figure 1A and 1C).
To define the activation status of DP T cells in chronic Chagas
patients, CD38 and HLA-DR surface markers were analyzed.
Since, it was previously reported that CD4
high/CD8
low and
CD4
low/CD8
high T cells differed in the expression of several
surface markers, phenotypic analysis was done separately [1–4,10].
The percentage of DP T cells expressing HLA-DR was three times
higher in CP in both CD4
high/CD8
low (p=0.0031) and CD4
low/
CD8
high (p=0.01) populations than in the two control groups. No
differences were observed between HC and NCC control groups
(Figure 2B). Representative flow cytometry density plots and
percentages of HLA-DR positive DP T cells are shown in
Figure 2A and Figure 2B, respectively. Analysis of CD38 in DP T
cells showed that CD4
high/CD8
low subset had increased (p=0.002)
percentage of cell expressing this marker in CP (X=38.9%622.0)
compared with NCC (9.665.3), and not different with HC
(20.6610.6). In contrast, the frequency of CD4
low/CD8
high
expressing CD38 was higher in CP (X=30.0%610.5)
(p=0.0001) when compared with both HC (12.667.7) and NCC
(11.0610.5). When co-expression of both activation markers
(CD38 and HLA-DR) was analyzed, CP doubled the percentage
of activated cells compared to HC and NCC donors in both
CD4
high/CD8
low (p=0.009) and CD4
low/CD8
high T cells
(p=0.001) (Figure 2A and 2C). There were no differences when
the analysis by clinical status was done. Due to the similarity of
both subsets of DP T cells (Table S1), data is presented on the
whole population in subsequent analyses.
Specificity and functional analysis of double positive T
cells
To assess the cytotoxic potential of DP T cells, intracellular
perforin was measured [10–11]. Increased (p=0.002) percentages
of cells containing perforin in CP (9.964.8) were found when
compared with HC (3.363.2) and NCC (3.362.9) donors.
Representative flow cytometry dot plots and percentage of
perforin positive cells are shown in Figures 3A and 3B,
respectively. No difference in perforin expression was found
(p=0.29) between asymptomatic (9.963.1) and symptomatic
(9.965.7) chagasic patients.
Next, the antigen specificity of DP T cells was determined. To
do so, the frequency of HLA-A*0201/peptide recognition was
assessed using epitopes from T. cruzi and influenza virus,
denominated K1 (Figure 4A) and MP-Flu (Figure 4B), respectively
[25]. We found that both asymptomatic (X=3.0%61.9) and
symptomatic (4.963.6) CP had higher percentages (p=0.0006) of
circulating DP T cells specific for the K1 cytotoxic epitope than
HC donors (0.660.4). There was no difference according to the
disease stage (p=0.267) (Figure 4C and Table S2). The percentage
of K1-specific DP T cells in the Chagasic donors was in average 27
times higher (p=0.0005) than the mono-CD8+ K1-specific ones
Figure 3. Functional characterization of DP T cells from
Chagasic patients and uninfected controls. (A) Representative
dot plot of perforin expression by CD4+/CD8+ T cells in chagasic
patients (CP), healthy controls (HC) and non-chagasic cardiomyopathy
(NCC) donors. DP T cells were selected as indicated in Figure 1A and the
percentage of perforin positive cell is shown in each quadrant. (B)
Percentages and average (line) of CD4+/CD8+ DP T cells expressing
perforin in CP, HC and NCC donors. *p,0.05 by Kruskal Wallis.
doi:10.1371/journal.pntd.0001294.g003
Double-Positive T Cells in Chagas Disease
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Representative flow cytometry dot plots and percentage of K1
specific DP T cells are shown in Figure 4A and Figure 4C,
respectively. Regarding MP-Flu response, asymptomatic
(3.961.5), symptomatic (2.962.0) and HC (3.662.0) donors had
similar percentages of specific DP T cells (p=0.39) for this viral
epitope. Representative flow cytometry dot plots and percentage of
MP-Flu specific DP T cells are shown in Figures 4B and 4D,
respectively.
Production of IFN-c and surface expression CD107 a/b, as
marker of degranulation, were analyzed in K1 tetramer-positive
DP T cells. The percentage of IFN-c positive cells in medium
alone was similar between asymptomatic (n=5) (0.48%60.45) and
symptomatic patients (n=6) (0.97%60.97) (p=0.52). Likewise, in
the presence of K1 peptide, asymptomatic patients (1.87%61.83)
showed a no significant increase in the percentage of IFN-c
positive cells when compared with the symptomatic group
(0.56%60.43) (p=0.26). However, after polyclonal stimulation
(SEB), this percentage was significantly higher in the asymptomatic
donors (14.6%610.3 versus 5.55%64.98; p=0.049). Representa-
tive flow cytometry dot plots and percentage of IFN-c positive cells
are shown in Figures 5A and 5B, respectively. Furthermore,
degranulation in K1 tetramer-positive DP T cells was significantly
higher in than symptomatic donors in the presence of K1 peptide
(21.50%613.38 versus 66.25%630.78; p=0.0455) and SEB
(24.74%621.74 versus 74.20%631.59; p=0.03); this seemed to
be also the trend for cell cultured in medium alone
(16.58%617.52 versus 67.0%632.93; p=0.052), in spite that no
significant difference between the asymptomatic and symptomatic
groups was found. Representative flow cytometry dot plots and
percentage of CD107a/b positive cells are shown in Figures 5A
and 5C, respectively.
Histology studies in cardiac tissue
Cardiac tissue from a chronic chagasic patient was analyzed in
order to identify the presence of CD4+/CD8+ cells. The
immunohistology analysis showed that myocardiocytes presented
reparative nuclear changes such as bigger size, hyperchromatic
and visible nucleoli. Moderate patchy myocardial infiltration
mostly conformed by lymphocytes, some plasmocytes, macro-
phages and scarce eosinophils was also observed. The number of
infiltrating lymphocytes was 10 or 12 per high power field, and
they were mostly CD8+ cells (near 95%, Figure 6A and 6B) and
some CD4+ cells (Figure 6B). Double CD4+/CD8+ cells were
found in the inflammatory infiltrate of the cardiac tissue in a
frequency lower than 2%, as shown in Figure 6C.
Discussion
Circulating CD4+/CD8+ double positive (DP) T cells represent
between 1–3% of the total T lymphocytes population [1].
However, previous evidence has suggested that this frequency
can increase during several inflammatory diseases [2–8]. In this
study we demonstrated that the percentage of peripheral DP T
Figure 4. Antigen specificity of DP T cells from Chagasic patients and uninfected controls. (A) Representative dot plots DP T cells specific
for K1 and (B) for MP-Flu tetramers in symptomatic CP (Sympt), asymptomatic CP (Asympt) donors and 5 healthy controls (HC). DP T cells were
selected as indicated in Figure 1A and the percentage of tetramer positive cells in shown in each quadrant. Percentages and average (line) of DP T
cells specific for K1 (C) and MP-Flu (D) peptides in chagasic patients and 5 uninfected donors (HC) typed for HLA-A*0201. *p,0.05 by Kruskal Wallis.
doi:10.1371/journal.pntd.0001294.g004
Double-Positive T Cells in Chagas Disease
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control donors, including individuals with non-chagasic cardio-
myopathy. This finding differs from previous studies in HVC and
HIV infected patients in which virus infected and control donors
did not have differences in DP T cells frequencies on peripheral
blood [10,26]. To the best of our knowledge, this research is the
first report of an augmented percentage of DP T cell in human
patients with a chronic parasitic infection.
Previous characterization of DP T cells indicates that this
lymphocyte subpopulation is constituted mainly by terminally
differentiated memory cells. A recent study showed that chronic
chagasic patients had higher frequencies of CD4+ effectors
memory T cells (TEM) and CD8+ central memory T cells (TCM)
when compared with uninfected individuals [27]. Interestingly, in
healthy donors CD4
high/CD8
low T cells were described as being
TEM phenotype, meanwhile CD4
low/CD8
high were mainly TCM
[10]. It will be interesting to determine if some of those CD4+ TEM
and CD8+ TCM described in chagasic patients could include some
DP T cells [27].
Similarly to DP T cells described in other human chronic
infectious diseases with antigen persistence [10,26,28,29], we
found that the expression of activation markers in these cells were
increased in the chagasic donors. Consistently, some studies in T.
cruzi infected donors have shown that their T cells (CD3+, CD3+/
CD4+ and CD3+/CD8+) tended to be more activated than cells
from uninfected donors [30–32].
Regarding the source of the peripheral DP T cells, experimental
data supports that they might either escape from the thymus [33]
or represents over-stimulated mono-positive CD4+ or CD8+ T
cells [34,35]. Interestingly, some studies have shown severe
CD4+CD8+ thymocytes depletion coexisting with 16-fold increase
of these cells in the periphery (subcutaneous lymph node) after T.
cruzi acute infection in mice [21,36]. These findings support the
‘‘thymus escape’’ theory. However, expression of the ‘‘second’’
Figure 5. IFN-c and CD107a/b expression by K1-tetramer positive DP T cells of Chagasic patients. (A) Representative dot plot of IFN-c
and CD107 expression by K1 Tet+/CD4+/CD8+ T cells in an asymptomatic (G0) and a symptomatic (G1–G3) chagasic patient. The percentage of IFN-c
and CD107 positive cells is shown in each quadrant. (B) Averaged percentage of IFN-c positive K1 Tet +/CD4+/CD8+ T cells in asymptomatic (G0, grey
bars) and symptomatic (G1–G3, black bars) chagasic patient. (C) Averaged percentage of CD107 positive K1 Tet+/CD4+/CD8+ T cells in asymptomatic
(G0, grey bars) and symptomatic (G1–G3, black bars) chagasic patient. SEB, Staphylococcal enterotoxin B. *p,0.05 by Mann Whitney.
doi:10.1371/journal.pntd.0001294.g005
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antigenic over-stimulation seems also plausible in our study, given
the consistent activation exhibited by the DP T cells [34]. More
studies are needed to determine the origin of DP T cells in
chagasic patients.
Perforin-mediated cytotoxicity has proved to be very important
in the protection and pathogenesis of some parasitic infection,
including cerebral malaria [37] and toxoplasmosis [38]. In animal
models, there is evidence that implicates perforin expression with
T. cruzi elimination during the acute disease [32,37]. However,
perforin has also been involved in tissue damage during chronic
Chagas disease [39–41]. After T. cruzi infection, perforin-
knockout mice had an increased parasite burden and increased
number of IFN-c producing T cells infiltrating their hearts.
However, these perforin-deficient animals showed more preserved
cardiac tissue and less electric conduction abnormalities than
normal littermates [39]. Even more, it has been suggested that
human cardiac damage is directly related to an increase in the
ratio of perforin-positive/total inflammatory cells in heart tissue
[40].
Another remarkable result in this study is that DP T cells can
recognized a T. cruzi derived class I epitope during chronic
infection. The percentage of DP T cells specific for the K1 peptide
was exceptionally high (1.7% to 11.5%) compared with previous
reports of K1 specificity for mono-CD8+ T lymphocytes (0.09% to
0.34%) in a similar chronic chagasic population [25]. Likewise, in
human viral infections (HCV and HIV) upon antigen exposure,
DP T cells displayed a much higher frequency of cell-single
cytokine production than CD8+ and CD4+ T cells [10,26].
Analysis of class I antigen recognition suggests that DP T cells in
chagasic patients were parasite driven. Probably, as these
peripheral cells are T. cruzi antigen-specific and have memory
phenotype, they could migrate to the tissue where parasites persist
and contribute to T. cruzi induced pathology. In fact, in situ
cytotoxic lymphocytes (perforin or granzyme A positive cells) have
been described in human heart [41] and gastrointestinal tract [42]
of patients with T. cruzi induced tissue damage.
When activation markers, perforin and K1-recognition on DP
T cells were compared in chagasic patients according to their
clinical status (asymptomatic versus symptomatic patients), no
differences were found. Nevertheless, it was notable that some
symptomatic donors had higher percentages of K1 T. cruzi specific
cells than asymptomatic ones, while percentages of recognitions
for influenza virus epitope were similar. We also found that K1
specific DP T cells from symptomatic group displayed increased
degranulation activity even with medium alone. However, very
low percentages of these K1 tetramer specific DP T cells produced
IFN-c after K1 peptide stimulation, as similarly described for
CD8+ T cells in chronic chagasic patients [25]. This was not the
case for the production of IFN-c after polyclonal stimulation,
which was significantly augmented especially in the asymptomatic
patients. Interestingly, K1 specific DP T cells that produce IFN-c
did not display degranulating phenotype, indicating that DP T
population is functionally heterogeneous and complex. In
summary, K1 specific cells from asymptomatic donors had higher
capacity of IFN-c secretion than cells from symptomatic donors
which have greater cytotoxic potential.
In our study, we found a higher expression of perforin on
peripheral DP T cells in the chagasic patients accompanied with
an increased degranulation activity in the symptomatic ones. Also,
it was demonstrated that DP T cells can migrated to the cardiac
tissue. If the blood phenotype of these cells is maintained by the
infiltrating ones, it might be possible to associate DP T cells with
cardiac damage. A similar mechanism was suggested for HCV
infected humans where DP T cells were found to infiltrate the liver
[10].
Progressive loss of cytokines secretion is a characteristic of
CD8+ T cells exhaustion, a phenomenon related to antigen
persistence during chronic infections [43]. Indeed, IFN-c that is
associated with protection against T. cruzi infection [44], is one of
the last effector activities to be extinguished in this process [43].
So, our data suggest that K1 specific DP T cells, mainly from
symptomatic donors, should be on the pathway of exhaustion,
while they keep their cytotoxic potential. Lastly, as TNFa
production has been associated with cardiac damage in Chagas
disease [45], it will be of interest to test the production of TNFa on
T. cruzi specific DP T cells.
Supporting Information
Table S1 Comparison of DP T cells among chagasic
donors according to the presence of symptoms. Modified
Figure 6. Staining for CD4 and CD8 in a chronic chagasic heart tissue. Immunochemistry for CD4 and CD8 staining in heart tissue from a
chronic chagasic donor with cardiomyopathy. Slides were colored with hematoxyline/eosin to evaluate cellular infiltration and the presence of
parasites. CD8+ cells yield a brown-color (arrows) and CD4+ a red-color end products (arrows head); DP T cells showed a red-brown color (wide
arrow). (A)4 0 6magnification, and (B) and (C) 1006objective magnification.
doi:10.1371/journal.pntd.0001294.g006
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Table S2 Percentages of K1-tetramer positive DP T
cells and mono-CD8+ T cells from chagasic patients. (A)
K1 positive DP T cells frequencies in asymptomatic versus
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